1. Home
  2. LXRX vs MVT Comparison

LXRX vs MVT Comparison

Compare LXRX & MVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • MVT
  • Stock Information
  • Founded
  • LXRX 1995
  • MVT 1993
  • Country
  • LXRX United States
  • MVT United States
  • Employees
  • LXRX N/A
  • MVT N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • MVT Investment Bankers/Brokers/Service
  • Sector
  • LXRX Health Care
  • MVT Finance
  • Exchange
  • LXRX Nasdaq
  • MVT Nasdaq
  • Market Cap
  • LXRX 124.4M
  • MVT 223.0M
  • IPO Year
  • LXRX 2000
  • MVT N/A
  • Fundamental
  • Price
  • LXRX $0.36
  • MVT $10.63
  • Analyst Decision
  • LXRX Buy
  • MVT
  • Analyst Count
  • LXRX 4
  • MVT 0
  • Target Price
  • LXRX $3.67
  • MVT N/A
  • AVG Volume (30 Days)
  • LXRX 9.5M
  • MVT 49.7K
  • Earning Date
  • LXRX 03-06-2025
  • MVT 01-01-0001
  • Dividend Yield
  • LXRX N/A
  • MVT 4.15%
  • EPS Growth
  • LXRX N/A
  • MVT N/A
  • EPS
  • LXRX N/A
  • MVT N/A
  • Revenue
  • LXRX $31,081,000.00
  • MVT N/A
  • Revenue This Year
  • LXRX N/A
  • MVT N/A
  • Revenue Next Year
  • LXRX $101.91
  • MVT N/A
  • P/E Ratio
  • LXRX N/A
  • MVT N/A
  • Revenue Growth
  • LXRX 2481.48
  • MVT N/A
  • 52 Week Low
  • LXRX $0.28
  • MVT $8.96
  • 52 Week High
  • LXRX $2.62
  • MVT $11.17
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 32.86
  • MVT 37.73
  • Support Level
  • LXRX $0.33
  • MVT $10.65
  • Resistance Level
  • LXRX $0.41
  • MVT $10.75
  • Average True Range (ATR)
  • LXRX 0.06
  • MVT 0.12
  • MACD
  • LXRX -0.02
  • MVT -0.04
  • Stochastic Oscillator
  • LXRX 16.38
  • MVT 11.11

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

About MVT Blackrock MuniVest Fund II Inc.

Blackrock Munivest Fund II Inc is a closed-end management investment company. The fund's objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes as is consistent with its investment policies and prudent investment management. The company invests in Transportation, Health, Utilities, Education, Housing, and other sectors.

Share on Social Networks: